Company: SUPN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042531
Chunk: 9

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 9
---
 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (10) Includes 126,750 shares of common stock issuable to Mr. Mottola that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (11) Includes 60,702 shares of common stock issuable to Dr. Barlow that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (12) Includes 88,043 shares of common stock issuable to Dr. Gemayel that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (13) Includes 88,043 shares of common stock issuable to Mr. Hudson that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (14) Includes 88,043 shares of common stock issuable to Mr. Newhall that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. (15) Includes 14,290 shares of common stock issuable to Ms. Sensenig that may be acquired at or within 60 days of April 22, 2025, pursuant to the exercise of outstanding options. 5

PROPOSAL 1
ELECTION OF DIRECTORS In April 2012, our stockholders approved the Company’s Amended and Restated Certificate of Incorporation, which divided the Board of Directors into three classes, as nearly equal in number as possible with one class standing for election each year for a three-year term. The term of the Class I directors will expire at the 2025 Annual Meeting of Stockholders, the term of the Class II directors will expire at the 2026 Annual Meeting of Stockholders and the term of the Class III directors will expire at the 2027 Annual Meeting of Stockholders. At each Annual Meeting of Stockholders, the successors of the class of directors whose term expires shall be elected to hold office for a term expiring at the Annual Meeting of Stockholders to be held in the third year following the year of their election, with each director in each such class to hold office until his or her successor is duly elected and qualified. Our Board of Directors shall not be fewer than five and not more than